Log In
Print this Print this

TARGTepo (MDGN-201) (formerly Epodure)

  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionTransdermal biopump implant device that produces erythropoietin (EPO)
Molecular Target Erythropoietin (EPO)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today